SCHEMBL7744174

SCHEMBL7744174

CC(=O)Nc1oc(-c2ncccc2-c2cccc(F)c2)nc1-c1ccccc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 7/20 0.66
FLT1 P17948 1/20 0.56
FLT4 P35916 1/20 0.56
ADORA3 P0DMS8 1/20 0.47
ADORA2A P29274 1/20 0.47
ADORA2B P29275 1/20 0.47
ADORA1 P30542 1/20 0.47
TOP2A P11388 1/20 0.44
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 2/20 0.40
LMNA P02545 2/20 0.40
NR4A2 P43354 1/20 0.40
ALOX15 P16050 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
NPC1 O15118 1/20 0.38
TSHR P16473 1/20 0.38
RAB9A P51151 1/20 0.38
HPGD P15428 1/20 0.38
TLR7 Q9NYK1 1/20 0.38
S100A4 P26447 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7746644 0.89 KDR (0.62) KDRFLT1FLT4ALDH1A1KDM4E
SCHEMBL7738998 0.89 KDR (0.57) KDRFLT1FLT4ADORA1ALDH1A1
SCHEMBL7744177 0.88 KDR (0.67) KDRFLT1FLT4ADORA2AADORA1
SCHEMBL7744677 0.87 KDR (0.53) KDRFLT1FLT4ADORA2AADORA1
SCHEMBL7739021 0.86 KDR (0.67) KDRFLT1FLT4ADORA3ADORA2A
SCHEMBL7746657 0.84 KDR (0.53) KDRFLT1FLT4ALDH1A1SMN1; SMN2
SCHEMBL7744668 0.76 KDR (0.69) KDRFLT1FLT4ADORA1ALDH1A1
SCHEMBL7983597 0.75 KDR (0.65) KDRFLT1FLT4ADORA3ADORA2A
SCHEMBL7739009 0.74 KDR (0.77) KDRFLT1FLT4ALDH1A1KDM4E
SCHEMBL7746582 0.72 KDR (0.62) KDRFLT1FLT4ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed